Firma Avisa Diagnostics Inc., Autor bei PR-Web

Avisa Diagnostics Appoints Dr. Richard Murray as Chief Medical Officer

Posted on 1. September 20212. September 2021 by Firma Avisa Diagnostics Inc. Posted in General Tagged align, allergy, avisa, biomarker, clinical, financial, market, medical, merck, patients, research, securities, statements, treatment, with

Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of virulent bacterial lung infections, is pleased to announce that the Company has hired Richard K. Murray, M.D., […]

Avisa Diagnostics to Participate at Upcoming Investor Events

Posted on 9. July 202110. July 2021 by Firma Avisa Diagnostics Inc. Posted in General Tagged avisa, biomarker, clinical, financial, market, medical, networks, renmark, risks, roadshow, securities, statements, stellar, webinar, with

Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of virulent bacterial lung infections, announced today that the Company will participate in several virtual investor events in […]

Avisa Diagnostics Appoints G. Michael Landis as Chief Financial Officer

Posted on 22. June 202123. June 2021 by Firma Avisa Diagnostics Inc. Posted in General Tagged avisa, biomarker, clinical, deloitte, financial, landis, market, medical, patients, securities, security, statements, strong, treatment, with

Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of bacterial load in post-COVID-19 long haulers and for ventilator-associated pneumonia, is pleased to announce that G. Michael […]

Avisa Diagnostics to Participate in Renmark’s Virtual Non-Deal Roadshow Series on June 17, 2021

Posted on 17. June 202117. June 2021 by Firma Avisa Diagnostics Inc. Posted in General Tagged ampa, avisa, biomarker, clinical, company, covid, diagnostics, financial, google, may, medical, roadshow, series, virtual, with

Avisa Diagnostics Inc. (CSE: AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of bacterial load in post-COVID-19 long haulers and for ventilator-associated pneumonia, announced today that the Company will […]